National Medical Products Administration

中文| Contact Us| search search nav

• Home+
• About NMPA+
  • Leadership
  • Our Responsibilities
  • NMPA Organizations
  • Affiliated Institutions
  • Contact Us
• News+
• Drugs+
• Medical Devices+
• Cosmetics+
• Resources+
  • Database
  • Worldwide Pharmacopoeia
  • Newsletter
  • Policies Interpretation
  • Popular Science

Database

About NMPA

• Leadership
• Our Responsibilities
• NMPA Organizations
• Affiliated Institutions
• Contact Us

Links

Related websites>

• World Health Organization
• State Council of the PRC
• Affiliated Institutions: National Institutes for Food and Drug Control Chinese Pharmacopoeia Commission Center for Drug Evaluation of NMPA Center for Food and Drug Inspection of NMPA Center for Drug Reevaluation of NMPA Center for Medical Device Evaluation of NMPA Center for Administrative Services and Complaints & Reports of NMPA Center for Administration Service of NMPA Information Center of NMPA NMPA Institute of Executive Development Certification Center for Licensed Pharmacist of NMPA News and Publicity Center of NMPA China Health-Media Group China Center for Food and Drug International Exchange NMPA Southern Medicine Economic Research Institute 146 Warehouse of NMPA Chinese Pharmaceutical Association Yangtze River Delta Center for Drug Evaluation and Inspection of NMPA Yangtze River Delta Center for Medical Device Evaluation and Inspection of NMPA Guangdong-Hong Kong-Macao Greater Bay Area Center for Drug Evaluation and Inspection of NMPA Guangdong-Hong Kong-Macao Greater Bay Area Center for Medical Device Evaluation and Inspection of NMPA
• Provincial Level Medical Products Administration: Beijing Tianjin Hebei Shanxi Inner Mongolia Liaoning Jilin Heilongjiang Shanghai Jiangsu Zhejiang Anhui Fujian Jiangxi Shandong Henan Hubei Hunan Guangdong Guangxi Hainan Chongqing Sichuan Guizhou Yunnan Tibet Shaanxi Gansu Qinghai Ningxia Xinjiang

News

• NMPA to enhance drug regulation under revised rules — committed to a people-centered healthy policy and strengthen high-effect regulation

  The revised Regulation aims to further encourage drug research and innovation, strengthen the whole life-cycle control of drugs and provide a solid legal guarantee for high-level drug safety and the high-quality development of the pharmaceutical industry.

• Li Li meets with head of BPOM of Indonesia

  On Nov 11, Li Li, commissioner of the National Medical Products Administration (NMPA), met in Beijing with a delegation led by Taruna Ikrar, head of the Food and Drug Supervisory Authority (BPOM) of Indonesia.

• Yang Sheng meets with WHO officials

  Yang Sheng, deputy commissioner of the National Medical Products Administration (NMPA), met with Rogerio Gaspar, Director of the Regulation and Prequalification Department of the World Health Organization (WHO) and WHO Representative to China, Martin Taylor, in Beijing on Nov 7.

Laws & Regulations

• NMPA Announcement on Matters Concerning the Importation of Pre-approval Commercial-Scale Batch Products of Overseas-Marketed Drugs (No. 96, 2025)
• Policy Interpretation of the NMPA Announcement on Matters Concerning the Importation of Pre-Approval Commercial-Scale Batch Products of Overseas-Marketed Drugs
• NMPA Notice on Issuing the Guidelines for On-Site Inspection of the Quality Management Specifications for Online Sales of Medical Devices NMPA Medical Device Supervision [2025] No. 14

Regulatory Information

• NMPA holds meeting to review QMS in vaccine regulation, pharmaceutical manufacturing inspection
• Netanasvir Phosphate Capsules Approved for Marketing by China NMPA
• Finotonlimab Injection Approved for Marketing by China NMPA

Policies Interpretation

• Policy measures to advance drug, medical device regulation reform

Popular Science

• Newcomers in operating room

Newsletter

• Volume VI 2025
• 2025 Special Issue for Cosmetics
• Volume V 2025
• Volume IV 2025
• 2025 Special Issue for Pediatric Drugs

About NMPA

• Leadership
• Our Responsibilities
• NMPA Organizations
• Affiliated Institutions
• Contact Us

Related websites>

• World Health Organization
• State Council of the PRC
• Affiliated Institutions: National Institutes for Food and Drug Control Chinese Pharmacopoeia Commission Center for Drug Evaluation of NMPA Center for Food and Drug Inspection of NMPA Center for Drug Reevaluation of NMPA Center for Medical Device Evaluation of NMPA Center for Administrative Services and Complaints & Reports of NMPA Center for Administration Service of NMPA Information Center of NMPA NMPA Institute of Executive Development Certification Center for Licensed Pharmacist of NMPA News and Publicity Center of NMPA China Health-Media Group China Center for Food and Drug International Exchange NMPA Southern Medicine Economic Research Institute 146 Warehouse of NMPA Chinese Pharmaceutical Association Yangtze River Delta Center for Drug Evaluation and Inspection of NMPA Yangtze River Delta Center for Medical Device Evaluation and Inspection of NMPA Guangdong-Hong Kong-Macao Greater Bay Area Center for Drug Evaluation and Inspection of NMPA Guangdong-Hong Kong-Macao Greater Bay Area Center for Medical Device Evaluation and Inspection of NMPA
• Provincial Level Medical Products Administration: Beijing Tianjin Hebei Shanxi Inner Mongolia Liaoning Jilin Heilongjiang Shanghai Jiangsu Zhejiang Anhui Fujian Jiangxi Shandong Henan Hubei Hunan Guangdong Guangxi Hainan Chongqing Sichuan Guizhou Yunnan Tibet Shaanxi Gansu Qinghai Ningxia Xinjiang

About NMPA

• Leadership
• Our Responsibilities
• NMPA Organizations
• Affiliated Institutions
• Contact Us

News Drugs Medical Devices Cosmetics Resources

• Database
• Worldwide Pharmacopoeia
• Newsletter
• Policies Interpretation
• Popular Science

Copyright © National Medical Products Administration All rights reserved. Presented by China Daily.

京ICP备13027807号-2